Michael Brock, former CEO of BK Medical, joins SuperSonic Imagine Supervisory Board

SuperSonic Imagine (Euronext: SSI, FR0010526814) a company specializing in ultrasound medical imaging equipment, announces that Michael Brock has joined the supervisory board of SuperSonic Imagine as Vice Chairman.

Michael Brock was the CEO of the Danish company BK Medical, a leader in ultrasound technology in the area of urology and surgery. His leadership experience in the field of ultrasound imaging is a strong asset for SuperSonic Imagine.

“We are pleased to welcome Michael Brock to the Board of SuperSonic Imagine. Michael’s deep expertise in commercializing innovative solutions in healthcare will be of great value to our global expansion strategy,” said Tom Egelund, Executive Vice President and Chief Operating Officer of SuperSonic Imagine.

As an additional change, Bernard Daugeras of Auriga Partners has stepped down from the board. Auriga Partners was the first fund to invest in SuperSonic Imagine in August 2005. They participated in each financing round since inception and also invested at the IPO. Auriga continues to support SuperSonic Imagine and remains a significant shareholder.

“I want to thank Auriga and in particular Bernard Daugeras for the trust and support provided over the past 10 years for SuperSonic Imagine. Bernard immediately understood the disruptive nature of our technology and the clinical benefits that could follow,” commented Jacques Souquet, President of the Executive Committee of SuperSonic Imagine and one of its founding members.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer® in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI. For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.